Omicron Vaccine Efficacy
- All
- News
- Videos
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
Covid Vaccines Show High Efficacy Against Severe Omicron: US Data
Covid-19 vaccines and boosters continued to have very high efficacy against severe outcomes during the Omicron wave of the virus, a large real-world study from the US Centers for Disease Control and Prevention (CDC) showed Friday.
-
Amid Omicron Fears, Government To Study Benefit Of Booster Dose: Sources
The government will conduct a medical study - on 3,000 fully vaccinated individuals - to assess the efficacy of a Covid vaccine booster against the Omicron variant, Health Ministry sources said Friday.
-
Case Data From UK, Vaccine Efficacy Mark Small Victories In Omicron Battle
Two vaccine manufacturers said their shots offered protection against Omicron, as UK data suggested it may cause proportionally fewer hospitalisations than the Delta coronavirus variant, supporting conclusions reached in South Africa.
-
No Evidence To Suggest That Existing Vaccines Don't Work On Omicron: Centre
There is no evidence to suggest that existing vaccines do not work on Omicron variant of coronavirus, though some of the mutations reported on spike gene may decrease the efficacy of existing vaccines, the Rajya Sabha was informed on Tuesday.
-
Pfizer Vaccine Cuts Omicron Hospitalisation By 70% In South Africa: Study
Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.
-
Coronavirus Highlights: 7,350 Fresh Covid Cases In India, 5.45% Lower Than Yesterday
The Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organization said Sunday.
-
Omicron Reduces Vaccine Efficacy, Spreads Faster, Says WHO
The Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organization said Sunday.
-
Do Current Vaccines Work On Omicron? Top WHO Expert's Reply
Preliminary evidence on Omicron suggests "higher transmissibility", WHO Regional Director for South East Asia Dr Poonam Khetrapal told NDTV today, adding that "regardless of the change in severity, increase in cases alone may pose overwhelming demand
-
Amid Omicron, Parliamentary Panel Wants Efficacy Of Existing Vaccines Checked
Amid growing concerns over the Omicron variant of SARS-CoV-2, a parliamentary committee has recommended that the efficacy of Covid vaccines must be evaluated and the government conduct more research for booster doses to contain the new strain.
-
Parliamentary Panel Recommends Evaluation Of Vaccines In View Of Omicron
Amid growing concerns over the new Omicron variant of SARS-CoV-2, a parliamentary committee has recommended that the efficacy of Covid vaccines must be evaluated and concerns with regards to the new strain.
-
Vaccines To Third Wave, Centre Answers Key Questions Amid Omicron Fears
While there is no evidence to suggest that existing vaccines do not work on the Omicron variant of SARS-CoV-2, some of the mutations reported may decrease the efficacy of the jabs, the Union Health Ministry said.
-
Moderna CEO Says World May Need New Vaccines To Fight Omicron
Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned Tuesday, as countries ramp up vaccination programmes and impose further restrictions to curb growing concern.
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
-
Covid Vaccines Show High Efficacy Against Severe Omicron: US Data
Covid-19 vaccines and boosters continued to have very high efficacy against severe outcomes during the Omicron wave of the virus, a large real-world study from the US Centers for Disease Control and Prevention (CDC) showed Friday.
-
Amid Omicron Fears, Government To Study Benefit Of Booster Dose: Sources
The government will conduct a medical study - on 3,000 fully vaccinated individuals - to assess the efficacy of a Covid vaccine booster against the Omicron variant, Health Ministry sources said Friday.
-
Case Data From UK, Vaccine Efficacy Mark Small Victories In Omicron Battle
Two vaccine manufacturers said their shots offered protection against Omicron, as UK data suggested it may cause proportionally fewer hospitalisations than the Delta coronavirus variant, supporting conclusions reached in South Africa.
-
No Evidence To Suggest That Existing Vaccines Don't Work On Omicron: Centre
There is no evidence to suggest that existing vaccines do not work on Omicron variant of coronavirus, though some of the mutations reported on spike gene may decrease the efficacy of existing vaccines, the Rajya Sabha was informed on Tuesday.
-
Pfizer Vaccine Cuts Omicron Hospitalisation By 70% In South Africa: Study
Two doses of Pfizer-BioNTech's COVID-19 vaccine appear to have given 70 per cent protection against hospitalisation in South Africa in recent weeks, according to a major real-world study which suggests weaker efficacy against the new Omicron variant.
-
Coronavirus Highlights: 7,350 Fresh Covid Cases In India, 5.45% Lower Than Yesterday
The Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organization said Sunday.
-
Omicron Reduces Vaccine Efficacy, Spreads Faster, Says WHO
The Omicron coronavirus variant is more transmissible than the Delta strain and reduces vaccine efficacy but causes less severe symptoms according to early data, the World Health Organization said Sunday.
-
Do Current Vaccines Work On Omicron? Top WHO Expert's Reply
Preliminary evidence on Omicron suggests "higher transmissibility", WHO Regional Director for South East Asia Dr Poonam Khetrapal told NDTV today, adding that "regardless of the change in severity, increase in cases alone may pose overwhelming demand
-
Amid Omicron, Parliamentary Panel Wants Efficacy Of Existing Vaccines Checked
Amid growing concerns over the Omicron variant of SARS-CoV-2, a parliamentary committee has recommended that the efficacy of Covid vaccines must be evaluated and the government conduct more research for booster doses to contain the new strain.
-
Parliamentary Panel Recommends Evaluation Of Vaccines In View Of Omicron
Amid growing concerns over the new Omicron variant of SARS-CoV-2, a parliamentary committee has recommended that the efficacy of Covid vaccines must be evaluated and concerns with regards to the new strain.
-
Vaccines To Third Wave, Centre Answers Key Questions Amid Omicron Fears
While there is no evidence to suggest that existing vaccines do not work on the Omicron variant of SARS-CoV-2, some of the mutations reported may decrease the efficacy of the jabs, the Union Health Ministry said.
-
Moderna CEO Says World May Need New Vaccines To Fight Omicron
Existing Covid-19 inoculations will struggle against the fast-spreading Omicron variant, the head of vaccine manufacturer Moderna warned Tuesday, as countries ramp up vaccination programmes and impose further restrictions to curb growing concern.
